Open AccessLaser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation
Author(s) -
Albert H. Kim,
Steven Tatter,
Ganesh Rao,
Sujit S. Prabhu,
Clark Chen,
Peter E. Fecci,
Veronica Chiang,
Kris A. Smith,
Brian J. Williams,
Alireza Mohammadi,
Kevin Judy,
Andrew E. Sloan,
Zulma Tovar-Spinoza,
James Baumgartner,
Constantinos G. Hadjipanayis,
Eric C. Leuthardt
Publication year - 2020
Publication title -
neurosurgery/neurosurgery online
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.485
H-Index - 34
eISSN - 1081-1281
pISSN - 0148-396X
DOI - 10.1093/neuros/nyaa071
Subject(s) - medicine , quality of life (healthcare) , comorbidity , ablation , radiation therapy , adverse effect , cancer registry , cancer , surgery , nursing
Laser Ablation of Abnormal Neurological Tissue using Robotic NeuroBlate System (LAANTERN) is an ongoing multicenter prospective NeuroBlate (Monteris Medical) LITT (laser interstitial thermal therapy) registry collecting real-world outcomes and quality-of-life (QoL) data.